Fortrea Holdings (FTRE) Income towards Parent Company (2022 - 2026)

Fortrea Holdings (FTRE) reported Income towards Parent Company of -$23.6 million for Q1 2026, down 285.83% quarter-over-quarter from $12.7 million in Q4 2024.

Fortrea Holdings (FTRE) Income towards Parent Company (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Income towards Parent Company for 4 years, with the latest figure at -$23.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company changed N/A year-over-year to -$23.6 million; the trailing twelve-month figure through Mar 2026 stood at -$23.6 million (up 34.08% YoY), and the FY2024 full-year result was -$57.0 million, down 976.92% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$23.6 million, down from $12.7 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $66.4 million in Q2 2022, with the low at -$39.1 million in Q2 2024.
  • Historically, Income towards Parent Company has averaged $3.3 million across 4 years, with a median of -$1.9 million in 2023.
  • The largest YoY upside for Income towards Parent Company was 315.25% in 2024 against a maximum downside of 774.14% in 2024.
  • Fortrea Holdings' Income towards Parent Company stood at -$13.6 million in 2022, then soared by 56.62% to -$5.9 million in 2023, then surged by 315.25% to $12.7 million in 2024, then slumped by 285.83% to -$23.6 million in 2026.
  • The last three Income towards Parent Company figures came in at -$23.6 million (Q1 2026), $12.7 million (Q4 2024), and -$9.4 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -23.60 Mn
Dec 31, 2024 12.70 Mn
Sep 30, 2024 -9.40 Mn
Jun 30, 2024 -39.10 Mn
Mar 31, 2024 -21.20 Mn
Dec 31, 2023 -5.90 Mn
Sep 30, 2023 2.10 Mn
Jun 30, 2023 5.80 Mn
Mar 31, 2023 4.50 Mn
Dec 31, 2022 -13.60 Mn
Sep 30, 2022 60.60 Mn
Jun 30, 2022 66.40 Mn